go back

Idecabtagene Vicleucel (Abecma) CAR-T Therapy

West Virginia rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $562,341 · 10th to 90th $389,045 to $562,341Professionalmedian $562,341 · 10th to 90th $562,341 to $562,341
$500K$1Mfacility $562,341professional $562,341

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$389,045.14
Median
$562,341.33
Typical High
$562,341.33
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
United
Setting
Professional
Modifier
Global
Typical Low
$831,763.77
Median
$831,763.77
Typical High
$831,763.77